Featured White Papers
- Enterprise PBX comparison guide (VoIP-News)
- Enterprise PBX buyer's guide (VoIP-News)
- Hosted CRM comparison guide (Inside CRM)
Health Care Industry
Industry: Email Alert RSS FeedImplantable cardioverter-defibrillator
Encyclopedia of Medicine by Lori De Milto
Definition
The implantable cardioverter-defibrillator is an electronic device to treat life-threatening heartbeat irregularities. It is surgically implanted.
Purpose
The implantable cardioverter-defibrillator is used to detect and stop serious ventricular arrhythmias and restore a normal heartbeat in people who are at high risk of sudden death.
The American Heart Association recommends that implantable cardioverter-defibrillators only be considered for patients who have a life-threatening arrhythmia. A recent study by the National Heart, Lung, and Blood Institute demonstrated that implantable cardioverter-defibrillators are the treatment of choice instead of drug therapy for patients who have had a cardiac arrest or heart attack and are at risk for developing ventricular tachycardia, which is a very rapid heartbeat, or ventricular fibrillation, which is an ineffective, irregular heart activity. Other studies suggest that 20% of these high risk patients would die within two years without an implantable cardioverter-defibrillator. With the device, the five-year risk of sudden death drops to five percent.
Precautions
The implantable cardioverter-defibrillator should not be used on patients who faint from causes other than a known life-threatening ventricular arrhythmia, to treat slow heart rates, or during an emergency.
Description
According to the American College of Cardiology, more than 80,000 Americans currently have an implantable cardioverter-defibrillator; 17,000 of these were implanted in 1995 alone. The battery-powered device rescues the patient from a life-threatening arrhythmia by rapid pacing and/or delivering electrical shock(s) to suspend heart activity and then allow it to initiate a normal rhythm. Before the development of the implantable cardioverter-defibrillator, most people who experienced ventricular fibrillation and weren't near a hospital with a well equipped emergency team died within minutes.
The implantable cardioverter-defibrillator is like a mini computer connected to the patient's heart. Newer models weigh less than 10 ounces and can be implanted beneath the skin of the chest in the pectoral region, without major surgery. A lead from the device is then inserted into the heart through a vein. The procedure is performed in an operating room under general anesthesia. Earlier versions of implantable cardioverter-defibrillators were implanted in the abdomen and required open-chest surgery to connect the electrodes to the left and right ventricles.
The implantable cardioverter-defibrillator is set above the patient's exercise heart rate. Once the device is in place, many tests will be conducted to ensure that the device is sensing and defibrillating properly. The newer implantable cardioverter-defibrillators last seven or eight years. Technology and procedures continue to evolve.
Preparation
Before the procedure, a complete medical history and physical exam will be done. Electrocardiography, special electrophysiologic testing, chest x ray, urinalysis, and a blood test are usually also required.